CVE-2020-25226

Description

A vulnerability has been identified in SCALANCE X-200 switch family (incl. SIPLUS NET variants) (All versions < V5.2.5), SCALANCE X-200IRT switch family (incl. SIPLUS NET variants) (All versions < V5.5.0). The web server of the affected devices contains a vulnerability that may lead to a buffer overflow condition. An attacker could cause this condition on the webserver by sending a specially crafted request. The webserver could stop and not recover anymore.

Categories

9.8
CVSS
Severity: Critical
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.84% Top 30%
Vendor Advisory siemens.com
Affected: Siemens SCALANCE X-200 switch family (incl. SIPLUS NET variants)
Affected: Siemens SCALANCE X-200IRT switch family (incl. SIPLUS NET variants)
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-25226?
CVE-2020-25226 has been scored as a critical severity vulnerability.
How to fix CVE-2020-25226?
To fix CVE-2020-25226, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-25226 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-25226 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-25226?
CVE-2020-25226 affects Siemens SCALANCE X-200 switch family (incl. SIPLUS NET variants), Siemens SCALANCE X-200IRT switch family (incl. SIPLUS NET variants).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.